<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01204281</url>
  </required_header>
  <id_info>
    <org_study_id>CEIC 10-48</org_study_id>
    <nct_id>NCT01204281</nct_id>
  </id_info>
  <brief_title>Proportional Assist Ventilation (PAV) in Early Stage of Critically Ill Patients</brief_title>
  <official_title>High-assistance Proportional Assist Ventilation (PAV) vs. Assist-Control Ventilation (ACV) in Early Stage of Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Althaia Xarxa Assistencial Universitària de Manresa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic - MITG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Althaia Xarxa Assistencial Universitària de Manresa</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the effectiveness of high assistance proportional assist ventilation (PAV+)
      (objective 80% gain) as main ventilatory support in early stage of critically ill patients in
      comparison with standard volume-assist control ventilation (ACV).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of this proposal is to apply PAV+ as routine ventilatory mode in the early stage of
      critically ill patients, taking advantages of spontaneous breathing and better
      patient-ventilator interaction.

      The standard treatment in patients with acute respiratory failure is mechanical ventilation
      in control-mode for the first days of acute illness. This procedure is usually associated
      with patient-ventilator dyssynchrony, higher needs of sedation and/or relaxation, muscle
      atrophy, etc. PAV + is a new ventilatory mode that applies pressure in proportion to
      spontaneous patient inspiratory effort allowing better adaptation to changes in internal
      homeostasis.

      Up to now, several reports compare PAV with assisted modes as a feasible alternative only in
      the weaning phase. However, PAV is able to unload patient effort in different levels,
      suggesting that high-assistance PAV (about 80%) could be comparable with assist-control modes
      in terms of respiratory muscles unload.

      Whether PAV is as effective as traditional ACV in terms of ventilation muscle unload in the
      acute phase of illness has not been established and we aim to address this question.

      We plan to prospectively enroll patients on mechanical ventilation early at ICU admission,
      and to ventilate them randomly under ACV (volume-assist control ventilation) or PAV+
      (beginning with 80% if possible). We will evaluate length of mechanical ventilation, sedation
      requirements and respiratory-hemodynamic variables from the very beginning and until
      attending clinicians decide that patients are ready to be weaned.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Length of mechanical ventilation</measure>
    <time_frame>28 days</time_frame>
    <description>Reduction of mechanical ventilation days when ventilated with high assistance PAV+ compared with ACV.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Non-inferiority of PAV+ compared to ACV in terms of gas exchange</measure>
    <time_frame>28 days</time_frame>
    <description>Non-inferiority of high assistance PAV+ compared to ACV in terms of gas exchange</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Noninferiority of PAV in short term complications</measure>
    <time_frame>28 days</time_frame>
    <description>Similar incidence in the complications composite outcome (barotrauma, ARDS, atelectasis and pneumonia)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Noninferiority of PAV in weaning success</measure>
    <time_frame>28 days</time_frame>
    <description>Similar rate of weaning success defined as the composite end-point: time to resume spontaneous ventilation, rate of extubation success, need for non invasive ventilation (NIV) as rescue therapy, and reintubation rate.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Respiratory Failure</condition>
  <condition>Mechanical Ventilation</condition>
  <arm_group>
    <arm_group_label>High assistance PAV+</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ventilatory support performed by PAV at 80% assistance (PB 840-plus) FiO2 and PEEP according to routine practice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Assist-control ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tidal volume, FiO2 and PEEP set according to routine practice</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mechanical ventilation mode (PAV+ vs. ACV)</intervention_name>
    <description>Compare two ventilatory modes in the acute phase of illness</description>
    <arm_group_label>High assistance PAV+</arm_group_label>
    <arm_group_label>Assist-control ventilation</arm_group_label>
    <other_name>Proportional Assist ventilation (PAV+)</other_name>
    <other_name>Assist Control ventilation</other_name>
    <other_name>Critically ill patients</other_name>
    <other_name>Mechanical ventilation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients 18 years of age or older

          -  Anticipated MV &gt; 24 hours

          -  Availability of informed consent from patient or next of kin

          -  Ventilation parameters measured under PAV+ 80% gain:

        PaO2/FiO2 &gt;100 RPAV &lt;10 cm H2O/l/s CPAV &gt; 30 ml/cm H2O WOBTOT &lt;1.5 J/l VE &lt;18 l/min

        Exclusion Criteria:

          -  Patients on moribund state or with life-sustaining therapy withholding decision.

          -  Patients with unstable respiratory/hemodynamic state, PaO2/FiO2 &lt;100, Dopamine &gt;15
             microg/Kg/min or epinephrine &gt;0.1 microg/kg/min.

          -  Pregnancy.

          -  Air leak.

          -  Patients needing deep sedation or muscle paralysis

          -  Patients needing hyperventilation (brain trauma).

          -  Patients with severe muscle weakness.

          -  Recruitment maneuvers or prone position.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rafael Fernandez, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Althaia Xarxa Assistencial Universitària de Manresa</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Intensive Care Unit. Xarxa assistencial Althaia.</name>
      <address>
        <city>Manresa</city>
        <state>Catalunya</state>
        <zip>08243</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <results_reference>
    <citation>Grasso S, Puntillo F, Mascia L, Ancona G, Fiore T, Bruno F, Slutsky AS, Ranieri VM. Compensation for increase in respiratory workload during mechanical ventilation. Pressure-support versus proportional-assist ventilation. Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):819-26.</citation>
    <PMID>10712328</PMID>
  </results_reference>
  <results_reference>
    <citation>Georgopoulos, D., Plataki, M., Prinianakis, G., Kondili, E., Current status of proportional assist ventilation. International journal of Intensive Care, 2007. Autumn: p. 19-26.</citation>
  </results_reference>
  <results_reference>
    <citation>Delgado M, Zavala E, Tomas R, Fernandez R. &quot;Feasibility of proportional assist ventilation as routine ventilatory support in intensive care patients&quot;. Intensive Care Med 2009; 35; Suppl 1: S125</citation>
  </results_reference>
  <results_reference>
    <citation>Putensen C, Muders T, Varelmann D, Wrigge H. The impact of spontaneous breathing during mechanical ventilation. Curr Opin Crit Care. 2006 Feb;12(1):13-8. Review.</citation>
    <PMID>16394778</PMID>
  </results_reference>
  <results_reference>
    <citation>Younes M. Proportional-assist ventilation. In: Tobin MJ, editor. Principles and practice of mechanical ventilation. Illinois: McGraw-Hill; 2006. p. 335-64.</citation>
  </results_reference>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 15, 2010</study_first_submitted>
  <study_first_submitted_qc>September 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 17, 2010</study_first_posted>
  <last_update_submitted>November 23, 2012</last_update_submitted>
  <last_update_submitted_qc>November 23, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 27, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Althaia Xarxa Assistencial Universitària de Manresa</investigator_affiliation>
    <investigator_full_name>Rafael Fernandez</investigator_full_name>
    <investigator_title>Head of Intensive Care Department</investigator_title>
  </responsible_party>
  <keyword>Proportional Assist Ventilation plus</keyword>
  <keyword>Acute respiratory failure</keyword>
  <keyword>Mechanical ventilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

